InvestorsHub Logo

lightrock

02/12/19 12:23 PM

#18327 RE: sab63090 #18326

That's why I mentioned the Israeli article, it appears indirect evidence of others trying already to copy this and get a foot in the door...

And yes, if this works it is just getting started.

On that note somebody brought up an article regarding even Multikine may owe its origins to something else that has come up before, and for that reason may be subject to litigation once there is money$.

It can make or break companies in this space. "collaborative effort" is great, but nobody with a job wants the other guy to succeed ( at least on one level )

Fosco1

02/12/19 12:30 PM

#18328 RE: sab63090 #18326

Thanks lots Sab
Of course if MK is successful Big Pharmas will have a look at it for H&N but for other types of cancer and indications
This will make the difference between a 20$ stock and a stock @ 200$. That's also why I do believe a possibility of this @200$ figure and, in case of success, I will urge people to wait & see. But at this point in time, let's be realistic, only matters the success of this trial and 0$ is also a possibility

alexander77

02/12/19 12:43 PM

#18329 RE: sab63090 #18326

Multikine can be applied to all solid tumors.